Georgia's Online Cancer Information Center

Find A Treatment Site

Piedmont Cancer Institute - Atlanta

Piedmont Cancer Institute, PC (formerly Peachtree Hematology-Oncology Consultants, PC) physicians are specialists in the treatment and prevention of cancer and blood disorders. The treatment philosophy includes the approach that during the healthcare experience at Piedmont Cancer Institute, PC, physicians are partners with the patient. The practice provides patients and their families with the most current medical knowledge and treatment available; education about your specific treatment; psychological and emotional support; access to community resources and support groups; and access to clinical trials and research protocols. The center is also a member of the Georgia CORE Research Network, a statewide network of academic and community-based oncologists and researchers.

Treatment Sites in Georgia

Clinical Trials in Georgia

A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF TALAZOPARIB WITH ENZALUTAMIDE IN METASTATIC CASTRATION-RESISTANT PROSTATE CANCER
Cancer Type: Prostate Cancer , Unknown Primary

A Phase II Trial Assessing the Accuracy of Tumor Bed Biopsies in Predicting Pathologic Response in Patients with Clinical/Radiologic Complete Response after Neoadjuvant Chemotherapy in Order to Explore the Feasibility of Breast Conserving Treatment without Surgery
Cancer Type: Breast Cancer

A Randomized, Open-Label, Multicenter Study of Eribulin Mesylate in Combination with PEGylated Recombinant Human Hyaluronidase (PEGPH20) versus Eribulin Mesylate Alone in Subjects with Human Epidermal Growth Factor Receptor 2 (HER2)-Negative, High-Hyaluronan (HA) Metastatic Breast Cancer
Cancer Type: Breast Cancer
Study Coordinator: Ann Johnston - 678-298-3235


GBM AGILE: Global Adaptive Trial Master Protocol: An International, Seamless Phase II / III Response Adaptive Randomization Platform Trial Designed To Evaluate Multiple Regimens In Newly Diagnosed and Recurrent GBM
Cancer Type: Unspecified

Radiation-Emitting SIR-Spheres in Non-resectable (RESIN) Liver Tumor Patient Study
Cancer Type: Liver Cancer

Randomized Blinded Phase III Assessment of Second or Third-Line Chemotherapy With Docetaxel + Plinabulin Compared to Docetaxel + Placebo in Patients With Advanced Non-Small Cell Lung Cancer and With at Least One Measurable Lung Lesion
Cancer Type: Lung Cancer
Study Coordinator: Ann Johnston - 678-298-3235


Single Arm, Open Label Phase 1b / 2 Study of SGN-LIV1A in Combination With Pembrolizumab for First-Line Treatment of Patients With Unresectable Locally-Advanced or Metastatic Triple-Negative Breast Cancer
Cancer Type: Breast Cancer
**GeorgiaCancerInfo is not a medical practice. This is an informational web site provided by Georgia CORE, a nonprofit striving to provide current and comprehensive information on cancer care in Georgia through this website. If you find erroneous or missing information, please contact us.
Georgia CORE

 

Advancing Cancer Care through Partnerships and Innovation

Georgia CORE is a public-private partnership that creates collaboration among the state’s cancer organizations and institutions to connect more Georgians to quality, personalized cancer care. We welcome you to this one-of-a-kind online information center for all things related to cancer and survivorship care in Georgia.